259
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007

, , , &
Pages 216-220 | Received 20 Oct 2008, Published online: 18 Nov 2009
 

Abstract

Our objective was to assess the incidence of amyotrophic lateral sclerosis (ALS), and its temporal variations, between 1997 and 2007. The study was based on data prospectively gathered by the referral ALS ‘expert centre’ of the Regional University Hospital of Limousin (710,792 inhabitants). Patients were included if they were diagnosed with ALS according to the revised El Escorial criteria either at the time of diagnosis or at subsequent follow-up, and if they resided in Limousin when diagnosed. We identified a high crude incidence (2.5/100,000). When age-standardized for the 1999 French population, the mean annual incidence was 2.0/100,000 inhabitants (95% CI 1.8–2.3) overall and 4.4 (95% CI 3.6–5.2) in the 45–74 years age group. Crude incidence by age groups showed a progressive increase up to 85 years, followed by a sharp decrease thereafter. Age at diagnosis was particularly high in our population (median, 69.4 years). Incidence of ALS in Limousin was consistent with previous work published by European population-based registries. The atypical epidemiology was explained in part by Limousin's older aged population. It is proposed that our referral centre will become a population-based registry.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.